MANAGED ASSET PORTFOLIOS, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1600999
ROCHESTER, MI
Position in TAK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$33,306,330
+$9,987,650 QoQ
Shares Held
1,798,398
+20.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
4.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79.49413867230724.ToString("F0")%
Shared 0.ToString("F0")%
None 20.505861327692756.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MANAGED ASSET PORTFOLIOS, LLC holds $34,371,047 across 2 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (96.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
1,798,398 | $33,306,330 | |
| 2 | ZTS |
Zoetis Inc.
|
9,007 | $1,064,717 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,306,330 | 1,798,398 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $23,318,680 | 1,495,746 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $21,761,013 | 1,486,408 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $23,017,512 | 1,488,843 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $21,853,933 | 1,469,666 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $18,767,011 | 1,417,448 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $23,001,433 | 1,617,541 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,878,327 | 1,613,472 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $23,386,259 | 1,683,676 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $25,087,815 | 1,758,081 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $26,862,354 | 1,736,416 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $26,881,773 | 1,711,125 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,191,848 | 1,467,952 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $22,923,076 | 1,469,428 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $18,959,726 | 1,461,814 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,285,005 | 1,444,801 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $20,046,252 | 1,399,878 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $15,892,961 | 1,166,028 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $19,913,968 | 1,215,749 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $20,300,144 | 1,206,188 | Shares | Sole | 2021-09-28 | |
| 2021-03-31 | $19,460,703 | 1,065,756 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,592,902 | 966,643 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $16,269,794 | 911,984 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $10,474,275 | 584,176 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,694,793 | 309,275 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||